Certara is a holding company. Through its subsidiaries, Co. delivers software products and technology-enabled services to customers to realize the benefits of biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions and market access. Co.'s End-to-End Platform provides software and technology-enabled services. Co. deploys its software to customers on public and private cloud networks, on-premises, and in data centers. Co.'s technology-enabled, biosimulation services help customers who do not have staff capability or availability to gain the benefits of biosimulation. Co. also provides related, technology-enabled services. The CERT stock yearly return is shown above.
The yearly return on the CERT stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CERT annual return calculation with any dividends reinvested as applicable (on ex-dates).
|